India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Today, the internet is an important part of our daily life. We use it to…
Dabur has appointed Mr. Herjit S Bhalla as the Chief Executive Officer (CEO) of Its…
Brazil has overtaken India as the leading exporter of the corn (maize) to Bangladesh. This…
Aligarh is a well-known city in Uttar Pradesh. It is popularly called the "City of…
The recent satellite based global study has revealed that the landfill sites in the Secunderabad…
The Appointments Committee of the Cabinet (ACC) has approved the three-year extension for the Managing…